70573-099Level 3
Ryplazim (plasminogen)
**Product type:** Plasma Derivative
**Active ingredient:** PLASMINOGEN
**Strength:** 68.8 mg/1
**Dosage form:** Injection, Powder, Lyophilized, For Solution
**Route:** Intravenous
**Labeler:** Kedrion Biopharma, Inc.
**Marketing category:** BLA (BLA125659)
GET
/api/v1/systems/ndc_fda/nodes/70573-099Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.